Sunshine Biopharma Inc. financial data

Symbol
SBFM, SBFMW on Nasdaq
Industry
Pharmaceutical Preparations
Location
333 Las Olas Way, Cu4 Suite 433, Fort Lauderdale, FL
State of incorporation
CO
Fiscal year end
December 31
Former names
Mountain West Business Solutions, Inc (to 11/2/2009), mountain west business solutions,inc (to 10/19/2007), mountain state business solutions,inc (to 5/25/2007)
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 481 % +9.35%
Quick Ratio 145 % +117%
Debt-to-equity 25.4 % -16.3%
Return On Equity -17.9 % +85.6%
Return On Assets -14.3 % +85.1%
Operating Margin -14.8 % +88.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2M shares -92.2%
Common Stock, Shares, Outstanding 2M shares -92.2%
Entity Public Float 10.7M USD -46.3%
Common Stock, Value, Issued 2K USD -92.2%
Weighted Average Number of Shares Outstanding, Basic 1.27M shares
Weighted Average Number of Shares Outstanding, Diluted 1.27M shares +9768%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33M USD +61.9%
Cost of Revenue 7.08M USD -45.9%
Research and Development Expense 1.6M USD +48.1%
General and Administrative Expense 15M USD -56.1%
Operating Income (Loss) -4.89M USD +81.9%
Nonoperating Income (Expense) 776K USD +24.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.11M USD +84.4%
Income Tax Expense (Benefit) 114K USD -72%
Net Income (Loss) Attributable to Parent -4.23M USD +84.2%
Earnings Per Share, Basic 117 USD/shares
Earnings Per Share, Diluted -2 USD/shares +74.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.7M USD -52.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.03K USD +9146%
Inventory, Net 9.82M USD +117%
Assets, Current 26M USD +2.15%
Property, Plant and Equipment, Net 591K USD +76.4%
Operating Lease, Right-of-Use Asset 541K USD -18.5%
Intangible Assets, Net (Excluding Goodwill) 2.94M USD +142%
Goodwill 0 USD
Assets 30.1M USD +8.7%
Accounts Payable, Current 4.16M USD +87.2%
Liabilities, Current 4.53M USD -11%
Operating Lease, Liability, Noncurrent 440K USD -20.8%
Liabilities 5.02M USD -11.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 169K USD -17.6%
Retained Earnings (Accumulated Deficit) -66.9M USD -6.75%
Stockholders' Equity Attributable to Parent 25M USD +14%
Liabilities and Equity 30.1M USD +8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.19M USD -72.2%
Net Cash Provided by (Used in) Financing Activities 5.4M USD
Net Cash Provided by (Used in) Investing Activities -669K USD -357%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Shares, Issued 2M shares -92.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12.2M USD -35.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 6.4M USD +14.3%
Depreciation 64.6K USD +73.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.26M USD +83.9%
Property, Plant and Equipment, Gross 556K USD +16.3%
Operating Lease, Liability, Current 116K USD -1.35%
Lessee, Operating Lease, Liability, to be Paid, Year Two 110K USD -5.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 116K USD +0.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 104K USD -5.66%
Deferred Tax Assets, Operating Loss Carryforwards 5.28M USD +22.1%
Preferred Stock, Shares Authorized 30M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 97.9K USD -5.66%
Additional Paid in Capital 91.7M USD +8.71%
Amortization of Intangible Assets 10.8K USD
Deferred Tax Assets, Net of Valuation Allowance 177K USD -41.3%
Interest Expense 145K USD +115%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares